Few and Far Between: How HIV May Be Evading Antibody Avidity
Author(s) -
Joshua S. Klein,
Pamela J. Björkman
Publication year - 2010
Publication title -
plos pathogens
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.719
H-Index - 206
eISSN - 1553-7374
pISSN - 1553-7366
DOI - 10.1371/journal.ppat.1000908
Subject(s) - human immunodeficiency virus (hiv) , foundation (evidence) , avidity , hiv vaccine , publication , data science , medicine , internet privacy , public relations , political science , virology , computer science , immunology , antibody , law , vaccine trial
The authors have declared that no competing interests exist. This work was conducted with support from the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (www.cavd.org) and the Grand Challenges in Global Health Initiative (www.grandchallenges.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom